Ubs Group Ag Axonics, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Axonics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 455,206 shares of AXNX stock, worth $32.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

455,206

Previous 293,585 55.05%

Holding current value

$32.3 Million

Previous $19.7 Million 60.68%

% of portfolio

0.01%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$67.3 - $69.67 $10.9 Million - $11.3 Million	161,621 Added 55.05%	455,206 $31.7 Million
Q2 2024 Aug 13, 2024	SELL	$66.47 - $69.65 $3 Million - $3.14 Million	-45,106 Reduced 13.32%	293,585 $19.7 Million
Q1 2024 May 13, 2024	BUY	$56.67 - $69.36 $15.9 Million - $19.5 Million	281,143 Added 488.54%	338,691 $23.4 Million
Q4 2023 Feb 09, 2024	BUY	$49.38 - $63.75 $1.51 Million - $1.95 Million	30,603 Added 113.58%	57,548 $3.58 Million
Q3 2023 Nov 09, 2023	SELL	$48.64 - $62.51 $780,136 - $1 Million	-16,039 Reduced 37.31%	26,945 $1.51 Million
Q2 2023 Aug 11, 2023	BUY	$47.99 - $60.21 $716,106 - $898,453	14,922 Added 53.18%	42,984 $2.17 Million
Q1 2023 May 12, 2023	BUY	$52.6 - $67.34 $430,846 - $551,581	8,191 Added 41.22%	28,062 $1.53 Million
Q4 2022 Feb 08, 2023	BUY	$59.56 - $76.6 $405,424 - $521,416	6,807 Added 52.11%	19,871 $1.24 Million
Q3 2022 Nov 10, 2022	BUY	$57.96 - $78.12 $307,303 - $414,192	5,302 Added 68.31%	13,064 $920,000
Q2 2022 Aug 10, 2022	SELL	$39.5 - $64.42 $53,759 - $87,675	-1,361 Reduced 14.92%	7,762 $440,000
Q1 2022 May 16, 2022	SELL	$43.74 - $62.76 $55,987 - $80,332	-1,280 Reduced 12.3%	9,123 $571,000
Q4 2021 Feb 14, 2022	BUY	$50.01 - $73.35 $15,753 - $23,105	315 Added 3.12%	10,403 $583,000
Q3 2021 Nov 15, 2021	BUY	$59.21 - $78.66 $37,124 - $49,319	627 Added 6.63%	10,088 $657,000
Q2 2021 Aug 13, 2021	BUY	$51.39 - $66.9 $314,095 - $408,892	6,112 Added 182.5%	9,461 $600,000
Q1 2021 May 12, 2021	BUY	$49.14 - $59.89 $81,867 - $99,776	1,666 Added 98.99%	3,349 $201,000
Q4 2020 Feb 11, 2021	BUY	$42.19 - $51.5 $24,343 - $29,715	577 Added 52.17%	1,683 $84,000
Q3 2020 Nov 12, 2020	SELL	$35.33 - $51.04 $238,194 - $344,111	-6,742 Reduced 85.91%	1,106 $56,000
Q2 2020 Jul 31, 2020	BUY	$22.91 - $39.83 $10,950 - $19,038	478 Added 6.49%	7,848 $276,000
Q1 2020 May 01, 2020	SELL	$16.44 - $37.73 $163,282 - $374,734	-9,932 Reduced 57.4%	7,370 $187,000
Q4 2019 Feb 14, 2020	BUY	$19.57 - $28.96 $107,693 - $159,366	5,503 Added 46.64%	17,302 $479,000
Q3 2019 Nov 14, 2019	BUY	$26.92 - $42.41 $248,579 - $391,613	9,234 Added 360.0%	11,799 $318,000
Q2 2019 Aug 14, 2019	BUY	$18.54 - $40.97 $38,785 - $85,709	2,092 Added 442.28%	2,565 $105,000
Q1 2019 May 14, 2019	SELL	$13.32 - $24.35 $45,288 - $82,790	-3,400 Reduced 87.79%	473 $11,000
Q4 2018 Feb 14, 2019	BUY	$13.2 - $16.43 $51,123 - $63,633	3,873 New	3,873 $59,000

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account